We develop & commercialize biopharmaceuticals addressing healthcare requirements in the areas of acute diseases, oncology and metabolic disorders. The products we work on include peptides, proteins, antibody fragments & gene therapy products based on recombinant technology, macromolecule conjugation as well as novel drug delivery technologies.